Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy (NCT01382082)
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment, at Six Month Follow-Up, and Long-Term Follow-Ups
🩺 Plain-English Summary (8th-Grade Level)
Cognitive impairments in cancer patients represent an important clinical problem. Studies to date estimating prevalence of difficulties in memory, executive function, and attention deficits have been limited by small sample sizes and many have lacked healthy control groups. More information is needed on promising biomarkers and allelic variants that may help to determine the etiology of impairment, identify those most vulnerable to impairment, and develop interventions for these difficulties. This is a longitudinal observational study of cognitive function in breast cancer and lymphoma patients receiving chemotherapy to better understand the prevalence of cognitive difficulties (i.e., problems with memory, executive function, and attention) in these populations.
Who can join: Review the eligibility criteria below.
Location: Delaware/Christiana Care NCORP — Newark, Delaware
Age range: 21 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (29 Sites)
Showing the first 25 of 29 sites.
- Delaware/Christiana Care NCORP — Newark, Delaware
- Delaware/Christiana Care NCORP (CHRISTIANA) — Newark, Delaware
- Heartland — Decatur, Illinois
- Kansas City Clinical Oncology Program — Prairie Village, Kansas
- Wichita NCORP — Wichita, Kansas
- Wichita — Wichita, Kansas
- Gulf South MU-NCORP — New Orleans, Louisiana
- Cancer Research Consortium of West Michigan — Grand Rapids, Michigan
- CRCWM — Grand Rapids, Michigan
- Metro Minnesota NCORP — Minneapolis, Minnesota
- Metro Minnesota Community Oncology Research Consortium — Saint Louis Park, Minnesota
- CCOP - Nevada Cancer Research Foundation — Las Vegas, Nevada
- Nevada — Las Vegas, Nevada
- Hem Onc CNY — East Syracuse, New York
- Kansas City — Rochester, New York
- University of Rochester Cancer Center — Rochester, New York
- Novant Health Cancer Institute - Kernersville — Winston-Salem, North Carolina
- Southeast Clinical Oncology Research Program — Winston-Salem, North Carolina
- Columbus NCORP — Columbus, Ohio
- Columbus — Columbus, Ohio
- Dayton Community Oncology Program — Dayton, Ohio
- Dayton — Dayton, Ohio
- Pacific Cancer Research Consortium Ncorp — Portland, Oregon
- PCRC — Portland, Oregon
- NCORP of the Carolinas — Greenville, South Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Anniston, Alabama
- [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer — Los Angeles, California
- Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery — Durham, North Carolina
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) — Palo Alto, California
- A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer — Chicago, Illinois
- ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer — Duarte, California
Explore by condition: All Breast Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.